- Zacks•2 days ago
Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.
- Business Wire•2 days agoTeva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntington Disease
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted the resubmission of the New Drug Application for SD-809 for the treatment of chorea associated with Huntington disease .
- Barrons.com•3 days ago
That's how Guggenheim analyst Louise Chen and team describe the potential impact on Mylan (MYL) due to generic EpiPen products from companies like Teva Pharmaceutical Industries (TEVA) and Impax Laboratories ...
Teva Pharmaceutical Industries Limited (TEVA.TA)
Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
|Bid||16,600.00 x 200|
|Ask||16,610.00 x 34100|
|Day's Range||16,450.00 - 16,610.00|
|52wk Range||160.20 - 16,610.00|
|1y Target Est||N/A|
|P/E Ratio (ttm)||11,095.52|
|Avg Vol (3m)||443,197|
|Dividend & Yield||N/A (N/A)|